本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

15.45
+0.19001.25%
盘后15.450.00000.00%16:04 EDT
成交量:123.08万
成交额:1,897.68万
市值:16.25亿
市盈率:-9.97
高:15.74
开:15.50
低:15.09
收:15.26
数据加载中...
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/19

重要事件披露

Form 8-K - Current report
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/15

重要事件披露

Form 8-K - Current report
2023/06/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]